Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals, Inc. | 0.83% | 745.68 | 2.6% | $767.75m | |
| AMGN | Amgen, Inc. | 0.34% | 233.82 | 1.4% | $621.98m | |
| MRNA | Moderna, Inc. | -0.04% | 125.62 | 0.0% | $612.25m | |
| BIIB | Biogen, Inc. | -2.15% | 261.69 | 1.8% | $573.08m | |
| GILD | Gilead Sciences, Inc. | 0.21% | 65.45 | 1.0% | $559.47m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.46% | 302.02 | 1.9% | $432.92m | |
| ILMN | Illumina, Inc. | 6.56% | 218.52 | 3.2% | $428.55m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | -1.21% | 4.08 | 0.7% | $285.21m | |
| SAVA | Cassava Sciences, Inc. | -1.80% | 40.97 | 0.0% | $181.06m | |
| BNTX | BioNTech SE | -0.28% | 137.19 | 0.0% | $112.04m | |
| TECH | Bio-Techne Corp. | 0.00% | 308.55 | 4.5% | $100.54m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 1.84% | 89.53 | 4.2% | $90.99m | |
| NVAX | Novavax, Inc. | -3.61% | 18.70 | 75.6% | $84.10m | |
| PRTA | Prothena Corp. Plc | 1.15% | 58.11 | 13.8% | $78.29m | |
| CRSP | CRISPR Therapeutics AG | -1.58% | 64.63 | 0.6% | $77.63m |
Company Profile
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.